Answers are grounded in this paper and cite their sources.
Significance T-cell alloreactivity drives transplant rejection. Alloreactive recognition is believed to proceed with limited specificity, accounting for the high numbers of alloreactive T cells in humans. Paradoxically, however, many T cells recognize alloantigens with high specificity, and receptors from such T cells are being explored for use in cancer immunotherapy. Here, we explain how a T-cell receptor (TCR) achieves high specificity toward a peptide antigen presented by allo-major histocompatibility complex (MHC). Counter to prevailing theories of alloreactivity, we find that TCR recognition is driven by a cooperative interplay between features unique to both the allo-MHC and the peptide, such that binding is both MHC- and peptide-centric. Our results have broad implications for the determinants of immune recognition and efforts in immunotherapy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: